{"id":"NCT01968954","sponsor":"Pfizer","briefTitle":"Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events","officialTitle":"A Phase 3 Double-blind,Randomized, Placebo-controlled,Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2016-04","completion":"2016-04","firstPosted":"2013-10-24","resultsPosted":"2017-05-17","lastUpdate":"2017-05-17"},"enrollment":711,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hyperlipidemia"],"interventions":[{"type":"DRUG","name":"Bococizumab (PF-04950615;RN316)","otherNames":["RN316"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Bococizumab (PF-04950615;RN316)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is a multicenter, randomized study in subjects with high cholesterol receiving highly effective statins to assess the efficacy, safety and tolerability of Bococizumab (PF-04950615;RN316) to lower LDL-C.","primaryOutcome":{"measure":"Percent Change From Baseline in Low Density Lipoprotein-Cholesterol (LDL-C) at Week 12","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Placebo","deltaMin":1,"sd":20.89},{"arm":"PF-04950615 150 mg","deltaMin":-55.6,"sd":29.17}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":103,"countries":["United States","Australia","Canada","Czechia","Germany","Hong Kong","Italy","Poland","South Korea"]},"refs":{"pmids":["37994400","37658997","35277540","31529318","29685591","28304227"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1481019&StudyName=Randomized%20Clinical%20Trial%20Of%20RN316%20%28PF-04950615%29%20In%20Subjects%20With%20Hyperlipidemia%20Or%20Mixed%20Dyslipidemia%20At%20Risk%20Of%20Cardiovascular%20Events"]},"adverseEventsSummary":{"seriousAny":{"events":40,"n":353},"commonTop":["Vitamin D deficiency","Nasopharyngitis","Injection site reaction","Upper respiratory tract infection","Bronchitis"]}}